Geneoscopy

Overview

St. Louis-based biotech company developing noninvasive RNA-based stool screening for gastrointestinal disease, including its FDA-approved ColoSense colorectal-cancer screening test; supported from its earliest days by BioGenerator, which invested in its seed and Series B rounds.

Key Facts

Sector

Biotechnology / Diagnostics

Focus Areas